Target intelligence / Profile preview

Ral guanine nucleotide dissociation stimulator like 4 (RGL4)

Target
RGL4
Molecular classification
Guanine nucleotide exchange factor (GEF), Signal transduction protein, Other (Ras effector protein family)
01

Overview

Ral guanine nucleotide dissociation stimulator like 4 (RGL4) is a protein-coding oncogene that encodes a guanine nucleotide exchange factor (GEF) similar to Ral guanine nucleotide dissociation stimulator. It activates small GTPases—specifically RalA and RalB—by promoting the exchange of GDP for GTP, playing a role in signal transduction from Ras to downstream pathways such as the Ras-Raf-MEK-ERK cascade. Increased expression results in protein translocation to the cell membrane and enhanced activation of signaling pathways involved in cell proliferation and oncogenesis. RGL4 is related to the Ras effector family and is implicated as a molecular contributor to cancer biology, but there are currently no direct interacting drugs or well-established biomarker or safety concern associations.

Other names
Ral-GDS-related proteinRGRhRGRRalGDS-like 4RgrRal guanine nucleotide dissociation stimulator-like 4RalGDS related oncogeneRal-GDS related protein RgrralGDS-like 4
02

Mechanism of action

Activation/inhibition of GEF activity and downstream Ral GTPases signaling

03

Biological functions

Signal transductionActivation of RalA and RalB GTPasesRegulation of intracellular signaling pathways, including Ras-Raf-MEK-ERK cascade
04

Disease associations

Cancer (oncogene function)

Beyond the preview

Go deeper on Ral guanine nucleotide dissociation stimulator like 4 (RGL4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ral guanine nucleotide dissociation stimulator like 4 (RGL4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call